CAROLINE ZIMMET: Open Payments
NPI 1932722758 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 13 payments from 4 companies in 2025. Trend: 2023 $282 · 2024 $388 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $254 |
| Lilly USA, LLC | 3 | $64 |
| Astellas Pharma US Inc | 1 | $21 |
| Corcept Therapeutics | 1 | $16 |
Products named: Wegovy, Saxenda, KISUNLA, Veozah, Korlym, MOUNJARO.
Industry payments across CA — which companies pay providers there.
